Literature DB >> 21744281

Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.

L M Søes1, I Brock, S Persson, J Simonsen, K E Pribil Olsen, M Kemp.   

Abstract

The purpose of this study was to compare clinical features of Clostridium difficile infection (CDI) to toxin gene profiles of the strains isolated from Danish hospitalized patients. C. difficile isolates were characterized by PCR based molecular typing methods including toxin gene profiling and analysis of deletions and truncating mutations in the toxin regulating gene tcdC. Clinical features were obtained by questionnaire. Thirty percent of the CDI cases were classified as community-acquired. Infection by C. difficile with genes encoding both toxin A, toxin B and the binary toxin was significantly associated with hospital-acquired/healthcare-associated CDI compared to community-acquired CDI. Significantly higher leukocyte counts and more severe clinical manifestations were observed in patients infected by C. difficile containing genes also encoding the binary toxin together with toxin A and B compared to patients infected by C. difficile harbouring only toxin A and B. In conclusion, infection by C. difficile harbouring genes encoding both toxin A, toxin B and the binary toxin were associated with hospital acquisition, higher leukocyte counts and severe clinical disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744281     DOI: 10.1007/s10096-011-1292-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains.

Authors:  H Kato; N Kato; S Katow; T Maegawa; S Nakamura; D M Lyerly
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

2.  A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.

Authors:  M Catherine McEllistrem; Robert J Carman; Dale N Gerding; C W Genheimer; L Zheng
Journal:  Clin Infect Dis       Date:  2004-12-15       Impact factor: 9.079

Review 3.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group.

Authors:  O Karlström; B Fryklund; K Tullus; L G Burman
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

5.  Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.

Authors:  Simon D Goldenberg; Gary L French
Journal:  J Infect       Date:  2011-03-21       Impact factor: 6.072

6.  Clostridium difficile in young children. Association with antibiotic usage.

Authors:  T Vesikari; E Isolauri; M Mäki; P Grönroos
Journal:  Acta Paediatr Scand       Date:  1984-01

7.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

Authors:  Barbara Geric; Robert J Carman; Maja Rupnik; Christopher W Genheimer; Susan P Sambol; David M Lyerly; Dale N Gerding; Stuart Johnson
Journal:  J Infect Dis       Date:  2006-03-06       Impact factor: 5.226

Review 9.  Clostridium difficile-associated disease: new challenges from an established pathogen.

Authors:  Rebecca H Sunenshine; L Clifford McDonald
Journal:  Cleve Clin J Med       Date:  2006-02       Impact factor: 2.321

Review 10.  The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea.

Authors:  Brian W Hurley; Cuong C Nguyen
Journal:  Arch Intern Med       Date:  2002-10-28
View more
  6 in total

1.  The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice.

Authors:  L M Søes; H M Holt; B Böttiger; H V Nielsen; M Torpdahl; E M Nielsen; S Ethelberg; K Mølbak; V Andreasen; M Kemp; K E P Olsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-19       Impact factor: 3.267

2.  Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC.

Authors:  Søren Persson; Joan N Jensen; Katharina E P Olsen
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

3.  Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Authors:  Claire Nour Abou Chakra; Allison McGeer; Annie-Claude Labbé; Andrew E Simor; Wayne L Gold; Matthew P Muller; Jeff Powis; Kevin Katz; Julian R Garneau; Louis-Charles Fortier; Jacques Pépin; Suzanne M Cadarette; Louis Valiquette
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

4.  Risk factors for Clostridium difficile infection in the community: a case-control study in patients in general practice, Denmark, 2009-2011.

Authors:  L M Søes; H M Holt; B Böttiger; H V Nielsen; V Andreasen; M Kemp; K E P Olsen; S Ethelberg; K Mølbak
Journal:  Epidemiol Infect       Date:  2013-09-27       Impact factor: 4.434

Review 5.  Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Stephanie Sirard; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

6.  Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.

Authors:  Yingchao Cui; Danfeng Dong; Lihua Zhang; Daosheng Wang; Cen Jiang; Qi Ni; Chen Wang; Enqiang Mao; Yibing Peng
Journal:  BMC Infect Dis       Date:  2019-11-11       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.